Cancer Treatment News and Research

RSS

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

UC researcher focuses on light-mediated therapies to target breast cancer

When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

17 Oct 2018

Patients once thought incurable can benefit from high-dose radiation therapy

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer.

17 Oct 2018

Women not warned about cancer associated with breast implants

Breast surgeons across the UK must ensure women are aware of BIA-ALCL, a non-Hodgkin’s lymphoma (a rare form of cancer) that is associated with implants; and more responsibility must be taken to diagnose and report cases, surgeons attending the 2018 London Breast Meeting have warned.

17 Oct 2018

New blood test could spare cancer patients from unnecessary chemotherapy

Cancer patients could be spared unnecessary chemotherapy - and its side effects - by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.

17 Oct 2018

Notable improvement in brain cancer survival among younger patients but not much for elderly

A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.

16 Oct 2018

New findings could benefit patients with triple-negative breast cancer

About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2.

12 Oct 2018

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs, a study to be presented at ESMO 2018 reported.

10 Oct 2018

Some cancer patients may benefit more from exercise than others

A new article in the Journal of the National Cancer Institute finds that some cancer patients appear to benefit more from exercise than others.

10 Oct 2018

Targeting a protein could be key for suppressing breast cancer metastasis, study suggests

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a protein known as collagen XIII could be key for suppressing breast cancer metastasis.

9 Oct 2018

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.

8 Oct 2018

Beyond BRCA: Epigenetic Silencing in Breast Cancer

An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.

8 Oct 2018

Scientists discover new molecular pathway that controls colorectal cancer development

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered a new molecular pathway that controls colorectal cancer development, and their exciting findings open new therapeutic opportunities.

8 Oct 2018

CPEN honors Penn Medicine's OncoLink with 2018 Excellence in Patient Education Award

The Cancer Patient Education Network (CPEN) honored the Patient Education Team from Penn Medicine's OncoLink with the 2018 Excellence in Patient Education Award.

8 Oct 2018

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus, putting vulnerable kids at risk for a serious infection.

5 Oct 2018

Yale researchers identify factors linked to disparities in cancer deaths

Yale researchers have identified factors that may contribute to widening cancer death disparities among counties across the United States.

5 Oct 2018

Frequent surveillance imaging not associated with improved overall postoperative survival

Cancer treatment continues to improve for many types of cancer, leading to increased life expectancy for many survivors.

5 Oct 2018

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

A robot could become the 'weapon' of choice for detecting and treating the most common cancer in men, improving results and reducing side effects.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

Stevens researchers develop new class of molecules for breast cancer treatment

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

4 Oct 2018

Cancer Treatment News and Research

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

UC researcher focuses on light-mediated therapies to target breast cancer

Patients once thought incurable can benefit from high-dose radiation therapy

Women not warned about cancer associated with breast implants

New blood test could spare cancer patients from unnecessary chemotherapy

Notable improvement in brain cancer survival among younger patients but not much for elderly

New findings could benefit patients with triple-negative breast cancer

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Some cancer patients may benefit more from exercise than others

Targeting a protein could be key for suppressing breast cancer metastasis, study suggests

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Beyond BRCA: Epigenetic Silencing in Breast Cancer

Scientists discover new molecular pathway that controls colorectal cancer development

CPEN honors Penn Medicine's OncoLink with 2018 Excellence in Patient Education Award

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

Yale researchers identify factors linked to disparities in cancer deaths

Frequent surveillance imaging not associated with improved overall postoperative survival

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Stevens researchers develop new class of molecules for breast cancer treatment

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News